HuGE Literature Finder
Records
1
-
30
| BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making. Cancers 2022 Sep 14 (19): . Pavese Francesco, Capoluongo Ettore Domenico, Muratore Margherita, Minucci Angelo, Santonocito Concetta, Fuso Paola, Concolino Paola, Di Stasio Enrico, Carbognin Luisa, Tiberi Giordana, Garganese Giorgia, Corrado Giacomo, Di Leone Alba, Generali Daniele, Fragomeni Simona Maria, D'Angelo Tatiana, Franceschini Gianluca, Masetti Riccardo, Fabi Alessandra, Mulè Antonino, Santoro Angela, Belli Paolo, Tortora Giampaolo, Scambia Giovanni, Paris I |
| Platinum Resistance After PARPi Resistance in a gBRCAmt Recurrent Ovarian Cancer Patient: a Case Report. Reproductive sciences (Thousand Oaks, Calif.) 2022 Aug . Zhao Qian, Ni Jing, Dong Jiayin, Cheng Xianzhong, Xiao Li, Xue Qi, Xu Xia, Guo Wenwen, Chen Xiaoxia |
| Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Jul . Pietzak Eugene J, Whiting Karissa, Srinivasan Preethi, Bandlamudi Chaitanya, Khurram Aliya, Joseph Vijai, Walasek Aleksandra, Bochner Emily, Clinton Timothy, Almassi Nima, Truong Hong, de Jesus Escano Manuel R, Wiseman Michal, Mandelker Diana, Kemel Yelena, Zhang Liying, Walsh Michael F, Cadoo Karen A, Coleman Jonathan A, Al-Ahmadie Hikmat, Rosenberg Jonathan E, Iyer Gopakumar V, Solit David B, Ostrovnaya Irina, Offit Kenneth, Robson Mark E, Stadler Zsofia K, Berger Michael F, Bajorin Dean F, Carlo Maria, Bochner Bernard |
| Breast Cancer with Low Recurrence Score on Oncotype DX Oncology and therapy 2022 Jun . Zarbiv Yonaton, Wygoda Yael Berner, Grinshpun Albert, Hamburger Tamar, Sella Tamar, Breuer Shani, Maimon Ofra, Rottenberg Yakir, Peretz Tamar, Kadouri Lu |
| Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial. International journal of cancer 2022 May . Koole Simone N, Schouten Philip C, Hauke Jan, Kluin Roel J C, Nederlof Petra, Richters Lisa K, Krebsbach Gabriele, Sikorska Karolina, Alkemade Maartje, Opdam Mark, Schagen van Leeuwen Jules H, Schreuder Henk W R, Hermans Ralph H M, de Hingh Ignace H J T, Mom Constantijne H, Arts Henriette J G, van Ham Maaike, van Dam Peter, Vuylsteke Peter, Sanders Joyce, Horlings Hugo M, van de Vijver Koen K, Hahnen Eric, van Driel Willemien J, Schmutzler Rita, Sonke Gabe S, Linn Sabine |
| Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score-matched analysis. Cancer 2022 May . Nero Camilla, Pasciuto Tina, Cappuccio Serena, Corrado Giacomo, Pelligra Silvia, Zannoni Gian Franco, Santoro Angela, Piermattei Alessia, Minucci Angelo, Lorusso Domenica, Fanfani Francesco, Scambia Giovan |
| Clinical outcomes and Oncotype DX Breast Recurrence Score® in early-stage BRCA-associated hormone receptor-positive breast cancer. Cancer medicine 2022 2 11 (6): 1474-1483. Layman Rachel M, Lin Heather, Gutierrez Barrera Angelica M, Karuturi Meghan S, Yam Clinton, Arun Banu |
| Comparison between talazoparib and conventional chemotherapy in the treatment of HER2-positive breast cancer patients: A retrospective study. Frontiers in immunology 2022 13 901636. Wang Ning, Yu Xiaope |
| Durable Disease-free Survival in a Patient with Metastatic Triple-negative Breast Cancer Treated with Olaparib Monotherapy. Current cancer drug targets 2022 2 22 (6): 530-536. Wang Xue, Hu Nanlin, Cui Lina, Si Yiran, Yue Jian, Zheng Fangchao, Kang Yikun, Yuan Pe |
| Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population. Annals of medicine 2021 Dec 53 (1): 1358-1369. Wang Liye, Zhai Qinglian, Lu Qianyi, Lee Kaping, Zheng Qiufan, Hong Ruoxi, Wang Shus |
| Outcomes after breast radiotherapy in a diverse patient cohort with a germline BRCA1/2 mutation. International journal of radiation oncology, biology, physics 2021 Oct . Chapman Bhavana V, Liu Diane, Shen Yu, Olamigoke Oluwafikayo O, Lakomy David S, Barrera Angelica M Gutierrez, Stecklein Shane R, Sawakuchi Gabriel O, Bright Scott J, Bedrosian Isabelle, Litton Jennifer K, Smith Benjamin D, Woodward Wendy A, Perkins George H, Hoffman Karen E, Stauder Michael C, Strom Eric A, Arun Banu K, Shaitelman Simona |
| Clinicopathological Features of BRCA1/2 Mutation-Positive Breast Cancer. Oncology 2021 Jun 1-8. Paik Hyun-June, Jung Youn Joo, Kim Dong Il, Lee Seungju, Jung Chang Shin, Kang Seok Kyung, Kim Jae-Joon, Oh So Yeon, Joo Ji Hyeon, Kim Hyun Y |
| Cisplatin +/- rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer. NPJ breast cancer 2021 Mar 7 (1): 29. Kalra Maitri, Tong Yan, Jones David R, Walsh Tom, Danso Michael A, Ma Cynthia X, Silverman Paula, King Mary-Claire, Badve Sunil S, Perkins Susan M, Miller Kathy |
| Combined breast conservation therapy versus mastectomy for BRCA mutation carriers - A systematic review and meta-analysis. Breast (Edinburgh, Scotland) 2021 Feb 56 26-34. Davey M G, Davey C M, Ryan É J, Lowery A J, Kerin M |
| Liquid Biopsy Cell-free DNA Biomarkers in Patients With Oligometastatic Colorectal Cancer Treated by Ablative Radiotherapy. Anticancer research 2021 Feb 41 (2): 829-834. Nakamura Masaki, Kageyama Shun-Ichiro, Seki Masahide, Suzuki Ayako, Okumura Masayuki, Hojo Hidehiro, Motegi Atsushi, Akimoto Tets |
| Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer. Journal of the National Cancer Institute 2021 12 114 (4): 565-570. Weber-Lassalle Konstantin, Ernst Corinna, Reuss Alexander, Möllenhoff Kathrin, Baumann Klaus, Jackisch Christian, Hauke Jan, Dietrich Dimo, Borde Julika, Park-Simon Tjoung-Won, Hanker Lars, Prieske Katharina, Schmidt Sandra, Weber-Lassalle Nana, Pohl-Rescigno Esther, Kommoss Stefan, Marmé Frederik, Heitz Florian, Stingl Julia C, Schmutzler Rita K, Harter Philipp, Hahnen Er |
| Locoregional Treatments and Ipsilateral Breast Cancer Recurrence Rates in BRCA1/2 Mutation Carriers. International journal of radiation oncology, biology, physics 2020 Nov . Bernstein-Molho Rinat, Laitman Yael, Galper Shira, Jacobson Galia, Boursi Ben, Gal-Yam Einav Nili, Kaufman Bella, Friedman Eitan, Kaidar-Person Or |
| Impact of the addition of carboplatin to anthracycline-taxane-based neoadjuvant chemotherapy on survival in BRCA1/2-mutated triple-negative breast cancer. International journal of cancer 2020 Jul . Zhang Juan, Yao Lu, Liu Yiqiang, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xie Yunt |
| Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 (26): 3012-3023. Lambertini Matteo, Ameye Lieveke, Hamy Anne-Sophie, Zingarello Anna, Poorvu Philip D, Carrasco Estela, Grinshpun Albert, Han Sileny, Rousset-Jablonski Christine, Ferrari Alberta, Paluch-Shimon Shani, Cortesi Laura, Senechal Claire, Miolo Gianmaria, Pogoda Katarzyna, Pérez-Fidalgo Jose Alejandro, De Marchis Laura, Ponzone Riccardo, Livraghi Luca, Estevez-Diz Maria Del Pilar, Villarreal-Garza Cynthia, Dieci Maria Vittoria, Clatot Florian, Berlière Martine, Graffeo Rossella, Teixeira Luis, Córdoba Octavi, Sonnenblick Amir, Luna Pais Helena, Ignatiadis Michail, Paesmans Marianne, Partridge Ann H, Caron Olivier, Saule Claire, Del Mastro Lucia, Peccatori Fedro A, Azim Hatem |
| Contralateral breast cancer and tumor recurrence in BRCA1/2 carriers and non-carriers at a high risk of hereditary breast cancer after bilateral mastectomy. Cirugia espanola 2020 Jun . Allué Cabañuz Marta, Domingo Bretón María, Chóliz Ezquerro Jorge, Arribas Del Amo María Dolores, Güemes Sánchez Antonio Tom |
| BRCA Mutation Association with Recurrence Score and Discordance in a Large Oncotype Database. Oncology 2020 Jan 1-4. Blanter Julia, Zimmerman Brittney, Tharakan Serena, Ru Meng, Cascetta Krystal, Tiersten A |
| Outcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation. Cancer medicine 2020 Jan . Ye Fugui, Huang Liang, Lang Guantian, Hu Xin, Di Genhong, Shao Zhimin, Cao Ayo |
| Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients. Translational oncology 2019 Dec 13 (2): 212-220. Gallardo-Rincón Dolores, Álvarez-Gómez Rosa María, Montes-Servín Edgar, Toledo-Leyva Alfredo, Montes-Servín Elizabeth, Michel-Tello David, Alamilla-García Gabriela, Bahena-González Antonio, Hernández-Nava Elizabeth, Fragoso-Ontiveros Veronica, Espinosa-Romero Raquel, Cetina-Pérez Luce |
| Identification of novel mutations of ovarian cancer-related genes from RNA-sequencing data for Japanese epithelial ovarian cancer patients. Endocrine journal 2019 Nov . Nagasawa Saya, Ikeda Kazuhiro, Horie-Inoue Kuniko, Sato Sho, Takeda Satoru, Hasegawa Kosei, Inoue Satos |
| Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers. Cancer 2019 Oct . Song Yun, Barry William T, Seah Davinia S, Tung Nadine M, Garber Judy E, Lin Nancy |
| Germline mutation in DNA-repair genes is associated with poor survival in BRCA1/2-negative breast cancer patients. Cancer science 2019 Aug . Fan Zhenhua, Hu Li, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xu Ye, Xie Yunt |
| Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers. Cancers 2019 May 11 (6): . Vocka Michal, Zimovjanova Martina, Bielcikova Zuzana, Tesarova Petra, Petruzelka Lubos, Mateju Martin, Krizova Ludmila, Kotlas Jaroslav, Soukupova Jana, Janatova Marketa, Zemankova Petra, Kleiblova Petra, Novotny Jan, Konopasek Bohuslav, Chodacka Martina, Brychta Milan, Sochor Marek, Smejkalova-Musilova Denisa, Cmejlova Vlastimila, Kozevnikovova Renata, Miskarova Lenka, Argalacsova Sona, Stolarova Lenka, Lhotova Klara, Borecka Marianna, Kleibl Zden |
| Analysis of Outcomes in Patients With BRCA1/2 Breast Cancer Mutations Treated With Accelerated Partial Breast Irradiation (APBI). American journal of clinical oncology 2019 Apr . Ahmed Faisal, Christos Paul J, Singh Prabhsimranjot, Parashar Bhupesh, Wernicke Alla Gabriel |
| Prevalence of germline variants in inflammatory breast cancer. Cancer 2019 Apr . Rana Huma Q, Sacca Rosalba, Drogan Christine, Gutierrez Stephanie, Schlosnagle Emily, Regan Meredith M, Speare Virginia, LaDuca Holly, Dolinsky Jill, Garber Judy E, Overmoyer Beth |
| Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with BRCA1 and BRCA2 mutation in China. Breast cancer research and treatment 2019 Mar . Cao Wei, Xie Yuntao, He Yingjian, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Ouyang T |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: